Cargando…
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death worldwide. Prognosis is poor, and therapeutic options are limited. MicroRNAs (miRNAs) have emerged as potential therapeutic molecules against cancer. Here, we investigated the therapeutic efficacy of miR-199a-3p, an m...
Autores principales: | Callegari, Elisa, D’Abundo, Lucilla, Guerriero, Paola, Simioni, Carolina, Elamin, Bahaeldin K., Russo, Marta, Cani, Alice, Bassi, Cristian, Zagatti, Barbara, Giacomelli, Luciano, Blandamura, Stella, Moshiri, Farzaneh, Ultimo, Simona, Frassoldati, Antonio, Altavilla, Giuseppe, Gramantieri, Laura, Neri, Luca Maria, Sabbioni, Silvia, Negrini, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992479/ https://www.ncbi.nlm.nih.gov/pubmed/29858083 http://dx.doi.org/10.1016/j.omtn.2018.04.002 |
Ejemplares similares
-
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus
por: Callegari, Elisa, et al.
Publicado: (2013) -
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer
por: Callegari, Elisa, et al.
Publicado: (2018) -
miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models
por: Callegari, Elisa, et al.
Publicado: (2022) -
miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models
por: Callegari, Elisa, et al.
Publicado: (2022) -
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs
por: Lupini, Laura, et al.
Publicado: (2013)